Eric S. Alonzo
Eric Alonzo is a dedicated professional with over 14 years of research experience focusing on complex biological systems to enhance human health, particularly in the realms of immunology, cancer biology, and gene therapy.
He aims to engineer superior immunotherapies, leading projects that integrate technology-driven approaches to develop innovative strategies for boosting immunity against cancer.
Eric has demonstrated expertise in project management, with a proven track record of leading, designing, and executing successful research projects and producing high-quality publications.
His educational background includes a Doctor of Philosophy (Ph.D.) in Cancer Biology from Gerstner Sloan-Kettering Graduate School of Biomedical Sciences at Memorial Sloan-Kettering Cancer Center and a Bachelor of Science (B.S.) in Cell and Molecular Biology from San Francisco State University.
Throughout his career, Eric has held various positions, including Associate Director in Analytical Development, CMC Lead for Early Oncology Programs, Senior Scientist, and Scientist roles at bluebird bio.
He has also worked as a Scientist in Immuno-oncology - Research and Development at Agenus and served as a Postdoctoral Research Fellow at Massachusetts General Hospital, Harvard Medical School.
Additionally, Eric has contributed to the scientific community as the Co-Chair and Board Member at NYC-MGSN and as a Research Technician II at the California Pacific Medical Center Research Institute.
Eric's specialties encompass Immunology, Cancer Biology, Gene Regulation, Signal Transduction, Gene Therapy, Project Management, and 18+ Color Flow Cytometry.
His passion for advancing knowledge in these areas is evident through his independent funding achievements and his eagerness to forge new professional connections.
To connect with Eric Alonzo and learn more about his work, reach out via email at eric.alonzo@agenusbio.com.